In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

A color vision test shows good correlation with cone and cone-rod dystrophy biomarkers and may offer a cost-effective replacement for ERG.

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Designed for people experiencing macular degeneration—the leading cause of vision loss among people over the age of 60—the glasses mimic insect eyes, which use anywhere from dozens to ...

Age-related macular degeneration (AMD), an acquired retinal disease that affects the macula, is the most common cause of irreversible vision loss in older adults. AMD is responsible for approximately ...

The company says that in pre-clinical tests performed on 30 people with macular degeneration, all of the participants experienced a reading speed increase of at least 50% when using the glasses.